(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.
Anixa Biosciences's earnings in 2026 is -$10,927,000.On average, 6 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,575,036, with the lowest ANIX earnings forecast at -$12,429,479, and the highest ANIX earnings forecast at -$8,410,926. On average, 5 Wall Street analysts forecast ANIX's earnings for 2027 to be -$11,121,113, with the lowest ANIX earnings forecast at -$12,756,571, and the highest ANIX earnings forecast at -$8,410,926.
In 2028, ANIX is forecast to generate -$11,575,036 in earnings, with the lowest earnings forecast at -$11,121,113 and the highest earnings forecast at -$11,915,478.